Addition of salmeterol to usual asthma pharmacotherapy may increase respiratory related deaths or life threatening experiences: Commentary

Evidence-Based Medicine

Volumn 11, Issue 5, 2006, Pages 139-

  Lipchik, Randolph J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALMETEROL;

AFRICAN AMERICAN; ANALYTICAL ERROR; ARTIFICIAL VENTILATION; ASTHMA; CAUSE OF DEATH; CLINICAL TRIAL; DRUG DOSE REGIMEN; ETHNIC DIFFERENCE; FOLLOW UP; HUMAN; INTUBATION; METERED DOSE INHALER; MORTALITY; PRESCRIPTION; RISK ASSESSMENT; SHORT SURVEY; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 33750358027     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.11.5.139     Document Type: Short Survey

References (1)

1. Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144:904-12.